Krismeikesari Krismeikesari. Comparative Efficacy and Safety of Finerenone, Eplerenone, and Spironolactone on Cardiorenal Outcomes in Type 2 Diabetes With Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis. OAIJMR 2025, 6, 1-20.